DRKS00013063进行中（未招募）不适用
Prospective, Open, Non-randomized, Non-interventional Explorative, Comparative, Uncontrolled Cohort Study for Post Market Clinical Follow-Up of the BPK-S Integration UC in the Variants CoCr or Ceramic as Primary Implant - 2017-02-BPK-S Comparison
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •*Congenital or acquired knee joint defects/deformation
- •*Defects or malfunction of the knee joint
- •*Arthrosis (degenerative, rheumatic)
- •*Post-traumatic arthritis
- •*Symptomatic knee instability
- •*Reconstruction of flexibility
- •*Patients with metal hypersensitivity (ceramic tibia/femur)
排除标准
- •*Illnesses which can be treated without using a knee joint implant.
- •*Acute or chronic infections near the implantation
- •*Systemic diseases and metabolic disorders
- •*Serious osteoporosis
- •*Serious damage to the bone structures that impedes stable implantation of the implant components
- •*Diseases that impair bone growth, e.g. cancer, renal dialysis, osteopenia, etc.
- •*Bone tumors in the area of the implant anchoring
- •*Obesity or overweight of the patient
- •*Overload of the knee implant to be expected
- •*Abuse of medication, drug abuse, alcoholism or mental disease
- •*Pregnancy
- •*Lack of patient cooperation
- •*Sensitivity to foreign matter in the implant materials
- •*Patients under the age of 18
- •*Patients participating in another trial
研究者
相似试验
尚未招募
4 期
A post marketing surveillance study of Moxifloxacin Hydrochloride solution to check its ability to prevent the growth or spread of bacteria & its safety in patient undergoing ophthalmic surgery.CTRI/2023/12/060575ovartis Healthcare Private Limited
进行中（未招募）
不适用
Prospective, randomized, open, crossover, patient preference study comparing oral immediate release and transdermal oxybutynin in overactive bladder patients•Male or female (18 – 80 years) suffering from OAB.•Symptoms of OAB as defined by:Urgency frequency =7 /week,•Urinary urgency incontinence (= 7 UIE/week),•Urodynamically proven detrusor instabilityMedDRA version: 9.1Level: LLTClassification code 10059617Term: Overactive bladderEUCTR2006-000475-16-DEJohannes Gutenberg-Universität Mainz, Urologische Klinik (ausführende Stelle), Prof. Dr. med. Thürof
尚未招募
不适用
Study to evaluate the safety and efficacy of NobiX system.CTRI/2022/05/042448Allevetix Medical Ltd
已完成
不适用
A clinical study, to find out the safety and performance of a medical device (Gastro Duodenal Sleeve) for weight loss in obese type II diabetic patients.CTRI/2017/12/010784Allevetix Ltd10
进行中（未招募）
不适用
Open, Prospective, Controlled, Randomised, Multicenter Phase II Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 versus Moist Wound Healing Dressing alone in Accelerating the Epithelialization of Split Thickness Skin Graft Donor SitesOleoSplit-Trial - OleoSplit-TrialEs handelt sich um eine offene, prospektive, kontrollierte, randomisierte, multizentrische Studie der Phase II, die eine intra-individuelle Wirksamkeit und Verträglichkeit des Oleogel-S10 mit einer feuchten Wundauflage im Hinblick auf einen Beschleunigung der Epithelialisierung der Wunde nach der Entnahme von Spalthaut mit einander vergleicht.EUCTR2009-017418-56-DEBirken GmbH80